Phase 3 data show subcutaneous teprotumumab significantly reduces proptosis in adults with active thyroid eye disease compared with placebo. Topline data were announced from a phase 3 trial evaluating ...
The Redback IFV (pictured above) weighs 42 tonnes and has a length, a width, and a height of 7.9 m, 3.64 m, and 3.75 m respectively. It has a maximum on-road speed of 65 km/h with a seating capacity ...
Brepocitinib is a first-in-class, oral, selective TYK2–JAK1 inhibitor that blocks cytokine signaling, which has been implicated in dermatomyositis. In this phase 3, double-blind, randomized, ...
Karyopharm Therapeutics faces heightened uncertainty after mixed phase 3 SENTRY results for selinexor in myelofibrosis. KPTI met the spleen volume reduction endpoint but missed symptom improvement ...
Selinexor added to ruxolitinib increased week-24 SVR35 rates versus ruxolitinib plus placebo, meeting a co-primary endpoint and reinforcing SVR35 as a clinically meaningful efficacy benchmark.
Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...
The biggest stories of the day delivered to your inbox.
A pre-specified interim analysis showed dual primary endpoint success, with improved PFS and OS versus physician’s-choice chemotherapy in taxane-progressed advanced TNBC. BL-B01D1-307 was a randomized ...
A phase 3 study of Gossamer Bio’s seralutinib in pulmonary arterial hypertension (PAH) has missed its primary endpoint, triggering a 77% crash in the biotech’s share price. The company has paused ...
Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.
Google has launched the Android Auto 16.3 update in the beta track. While there are no major user-facing changes, this version reportedly includes hints of video apps and the light theme. Google has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results